EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias evaluation by programmed stimulation and ambulatory electrocardiogram






Journal of the American College of Cardiology 8(4): 949-958

Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias evaluation by programmed stimulation and ambulatory electrocardiogram

Programmed ventricular stimulation and ambulatory electrocardiography were performed both before and during oral sotalol therapy in 39 patients with ventricular tachyarrhythmia inducible by programmed stimulation (sustained ventricular tachycardia [n = 31], ventricular fibrillation [n = 3], nonsustained ventricular tachycardia [n = 5]). Oral sotalol was started at 80 mg twice daily and the dose thereafter was then gradually increased until a mean dose of 300 mg (range 160-480) was reached. In 12 of 34 patients with inducible sustained ventricular tachycardia or fibrillation the arrhythmia was suppressed; in 19 patients it was not and in 3 the spontaneous arrhythmia recurred. Reproducibly inducible nonsustained ventricular tachycardia was suppressed by sotalol in all five patients with this arrhythmia. Thus, a favorable electrophysiologic response was obtained in 17 (44%) of 39 patients. Arrhythmia suppression correlated with the type of arrhythmia (unsustained or sustained) induced during the control period (p < 0.05), and nonresponders had a higher incidence of previously ineffective drug trials (p < 0.05). In 22 patients treated long term with sotalol suppression of arrhythmia inducibility on programmed stimulation predicted freedom from recurrences (16 of 17), whereas continued inducibility indicated drug failure (5 of 5) (p < 0.005). Serial ambulatory electrocardiograms performed in 37 of the 39 patients did not correlate with the results of electrophysiologic testing. For the patients on long-term treatment, invasive testing was superior to electrocardiographic monitoring in predicting outcome. These data indicate that in daily doses of 160 to 480 mg (1) oral sotalol is a very useful agent in patients presenting with sustained ventricular tachycardia or fibrillation, and (2) its efficacy is fairly well predicted by programmed stimulation.

Accession: 005349240

PMID: 3760368

DOI: 10.1016/s0735-1097(86)80440-5

Download PDF Full Text: Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias evaluation by programmed stimulation and ambulatory electrocardiogram



Related references

Programmed stimulation but not 24 hour electrocardiogram predicts efficacy of oral sotalol in sustained ventricular tachycardia. American Heart Association Monograph (114): III-171, 1985

Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents. American Journal of Cardiology 72(4): 56a-66a, 1993

Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia. Journal of Cardiovascular Pharmacology 21(1): 95-100, 1993

Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias. European Heart Journal 14 Suppl H: 85-87, 1993

Evaluation of oral sotalol in sustained ventricular tachycardia by programmed stimulation. European Heart Journal 6(ABSTR SUPPL 1): 3, 1985

The value of the signal-averaged electrocardiogram and electrophysiologic study for prediction of the efficacy of sotalol in patients with sustained ventricular tachycardia. European Heart Journal 14(ABSTR SUPPL ): 452, 1993

Evaluation of antiarrhythmic efficacy of sotalol in various doses in patients with ventricular tachyarrhythmias. Polski Merkuriusz Lekarski 2(8): 122-125, 1997

Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation. American Heart Journal 110(4): 774-784, 1985

Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. Circulation 72(3): 555-564, 1985

Acute antiarrhythmic efficacy of iv and oral d satolol in patients with sustained ventricular tachyarrhythmias. Journal of the American College of Cardiology 19(3 SUPPL A): 244A, 1992